High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.8M
$1,764,000
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
Other
|
2026-02-17 | $81,000 | M | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
10b5-1 Sell
|
2026-02-17 | $337,680x2 | S | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
Equity Compensation
|
2025-12-15 | $81,000x2 | M | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
10b5-1 Sell
|
2025-12-15 | $415,590x2 | S | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
Other
|
2025-11-19 | $81,000 | M | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
10b5-1 Sell
|
2025-11-19 | $336,000x2 | S | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
Other
|
2025-10-24 | $81,000 | M | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
10b5-1 Sell
|
2025-10-24 | $336,000x2 | S | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
Other
|
2025-09-15 | $81,000 | M | Form 4 |
| ADMA |
ADMA BIOLOGICS, INC.
|
CEO
10b5-1 Sell
|
2025-09-15 | $338,730x2 | S | Form 4 |